Simplifying Global Compliance
The QMN Weekly Bulletin
Hospira, CSL Biotherapies Recall Drugs on Manufacturing Issues
April 20, 2012
Hospira is recalling one lot of its morphine sulfate injection and CSL Biotherapies is recalling a number of batches of an albumin intravenous solution after both companies found manufacturing irregularities. Hospira’s recall involves one lot of its morphine sulfate injection delivered in a Carpuject syringe system. The recall comes after a customer report that two Carpuject syringes contained more than the appropriate fill volume.
Drug Industry Daily
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing